Pasithea Therapeutics Corp saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $17.40 on 12/11/23, while the lowest price for the same duration was marked at $3.61 on 09/10/24.
52-week price history of KTTA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Pasithea Therapeutics Corp’s current trading price is -63.41% away from its 52-week high, while its distance from the 52-week low is 76.35%. The stock’s price range during the 52-week period has remained between $3.61 and $17.40. In the Healthcare sector, the company’s shares saw a trading volume of around 44.92 million for the day, which was evidently higher than the average daily volume of 17540.0 over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Pasithea Therapeutics Corp (KTTA) has experienced a quarterly rise of 21.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.62M and boasts a workforce of 8 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.34, with a change in price of -0.96. Similarly, Pasithea Therapeutics Corp recorded 448,622 in trading volume during the last 100 days, posting a change of -13.81%.
Examining KTTA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for KTTA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
KTTA Stock Stochastic Average
Pasithea Therapeutics Corp’s raw stochastic average for the past 50 days is presently 61.82%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 61.82%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 27.89% and 20.58%, respectively.
KTTA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -13.97%.However, over the last six months, we can see a stronger performance of -8.71%. Over the last 30 days, the price of KTTA has fallen by 38.09%. And in the last five days, it has surged by 32.63%.
